---
title: "Dr. Reddy's Laboratories Ltd Stock 12‑Month Price Target Cut to $13.78, Implies 11% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286230801.md"
description: "Dr. Reddy's Laboratories Ltd's average stock price target has been reduced from $14.34 to $13.78, indicating an 11% potential upside based on the May 12 closing price. The consensus rating remains a 'Hold' among 30 analysts, with 8 Buy, 10 Hold, and 12 Sell recommendations. Forecasts for the stock range from $10.87 to $18.36 per share."
datetime: "2026-05-13T09:20:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286230801.md)
  - [en](https://longbridge.com/en/news/286230801.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286230801.md)
---

# Dr. Reddy's Laboratories Ltd Stock 12‑Month Price Target Cut to $13.78, Implies 11% Upside

-   According to estimates from 28 analysts, Dr. Reddy's Laboratories Ltd stock's average price target has fallen from $14.34 to $13.78, with forecasts ranging from $10.87 to $18.36 per share
-   Based on the May 12 closing price, the updated target implies approximately 11% potential upside
-   Consensus rating remains at “Hold” across 30 covering analysts, with 8 Buys, 10 Holds and 12 Sells

Explore more price target data and ratings for Dr. Reddy's Laboratories Ltd on the , and track all previous and future analyst recommendations for Dr. Reddy's Laboratories Ltd in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [RDY.US](https://longbridge.com/en/quote/RDY.US.md)

## Related News & Research

- [Dr Reddy's Laboratories launches generic Semaglutide injection in Canada](https://longbridge.com/en/news/286635919.md)
- [Dr Reddy's unveils oral diabetes drug Obeda for type 2 patients in India](https://longbridge.com/en/news/287073753.md)
- [Wynn Resorts Stock: Analyst Estimates & Ratings](https://longbridge.com/en/news/287068286.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Dr. Reddy’s posts audio of March-quarter 2026 earnings call for investors](https://longbridge.com/en/news/286145430.md)